Expression of an anti-botulinum toxin A neutralizing single-chain Fv recombinant antibody in transgenic tobacco

Kurt C. Almquist(University of Guelph), Michael D. McLean(University of Guelph), Yongqing Niu(University of Guelph), Greg Byrne(University of Guelph), Fernando C. Olea-Popelka(University of Guelph), Coral L. Murrant(University of Guelph), J. K. Barclay(University of Guelph), J. Christopher Hall(University of Guelph)

Vaccine

December 2, 2005

10.1016/j.vaccine.2005.11.014

Cited by 49

Abstract

Related Papers

Plant Molecular Biology Manual

Stanton B. Gelvin, Robbert A. Schilperoort, Desh Pal S. Verma|Unknown|1990|1.1k

Medical Aspects of Chemical and Biological Warfare

Frederick R. Sidell, Ernest T. Takafuji, David R. Franz|Unknown|1997|696

Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.

Elliott M. Antman, T. Wenger, V P Butler et al.|Circulation|1990|393

Antibodies and Genetically Engineered Related Molecules: Production and Purification

Ana Cecília A. Roque, Christopher R. Lowe, M. Ângela Taipa|Biotechnology Progress|2004|357

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody

A Nowakowski, C. Wang, David B. Powers et al.|Proceedings of the National Academy of Sciences|2002|328